SCHEMBL31751216

SCHEMBL31751216

C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CN)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.43
▸ OPRD1 P41143 4/20 0.43
▸ CAPN1 P07384 4/20 0.42
▸ APLNR P35414 1/20 0.41
▸ REN P00797 1/20 0.39
▸ ACE P12821 2/20 0.39
▸ CALCRL Q16602 2/20 0.38
▸ PSMB9 P28065 1/20 0.38
▸ CTSB P07858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30712732 0.97 CAPN1 (0.47) OPRM1OPRD1CAPN1APLNRCTSB
SCHEMBL31750671 0.97 CAPN1 (0.47) OPRM1OPRD1CAPN1APLNRCTSB
SCHEMBL29554130 0.96 CAPN1 (0.47) OPRM1OPRD1CAPN1APLNRCTSB
SCHEMBL29691873 0.92 CAPN1 (0.47) OPRM1OPRD1CAPN1APLNRCTSB
SCHEMBL29397223 0.92 CAPN1 (0.46) OPRM1OPRD1CAPN1APLNRREN
SCHEMBL31752319 0.92 CAPN1 (0.46) OPRM1OPRD1CAPN1APLNRREN
SCHEMBL31751644 0.91 OPRM1 (0.43) OPRM1OPRD1CAPN1APLNRREN
SCHEMBL29691750 0.90 CAPN1 (0.54) OPRM1OPRD1CAPN1APLNRCALCRL
SCHEMBL29554458 0.89 CAPN1 (0.54) OPRM1OPRD1CAPN1APLNRCALCRL
SCHEMBL30641527 0.89 APLNR (0.45) OPRM1OPRD1CAPN1APLNRREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025264785-A1 CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF NEUROCRINE BIOSCIENCES, INC. (US) 2025-12-26 — — WO claimed
WO-2025264785-A1 CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF NEUROCRINE BIOSCIENCES, INC. (US) 2025-12-26 — — WO disclosed
WO-2025264809-A1 CHEMICALLY MODIFIED PEPTIDES AND USE THEREOF NEUROCRINE BIOSCIENCES, INC. (US) 2025-12-26 — — WO disclosed
Send feedback